Legend Biotech Corporation (LEGN)
USD 30.16
(-5.8%)
USD 30.16
(-5.8%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 328.67 Million USD | 15.51% |
| 2022 | 284.53 Million USD | 131.39% |
| 2021 | 122.96 Million USD | 3545.6% |
| 2020 | 3.37 Million USD | -44.57% |
| 2019 | 6.08 Million USD | 40.95% |
| 2018 | 4.31 Million USD | 1504.83% |
| 2017 | 269 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 334.68 Million USD | 1.83% |
| 2024 Q2 | 338.92 Million USD | 1.27% |
| 2023 Q1 | 314.76 Million USD | 10.62% |
| 2023 Q4 | 328.67 Million USD | 2.55% |
| 2023 Q2 | 318.61 Million USD | 1.22% |
| 2023 FY | 328.67 Million USD | 15.51% |
| 2023 Q3 | 320.5 Million USD | 0.59% |
| 2022 Q1 | 129.22 Million USD | 5.09% |
| 2022 Q4 | 284.53 Million USD | 0.0% |
| 2022 Q3 | - USD | -100.0% |
| 2022 FY | 284.53 Million USD | 131.39% |
| 2022 Q2 | 195.72 Million USD | 51.45% |
| 2021 Q1 | 3.13 Million USD | -7.12% |
| 2021 FY | 122.96 Million USD | 3545.6% |
| 2021 Q4 | 122.96 Million USD | 67.25% |
| 2021 Q3 | 73.52 Million USD | 265.61% |
| 2021 Q2 | 20.1 Million USD | 541.84% |
| 2020 Q4 | 3.37 Million USD | -15.42% |
| 2020 FY | 3.37 Million USD | -44.57% |
| 2020 Q2 | 3.43 Million USD | -27.82% |
| 2020 Q1 | 4.75 Million USD | -21.84% |
| 2020 Q3 | 3.98 Million USD | 16.17% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 6.08 Million USD | 40.95% |
| 2019 Q4 | 6.08 Million USD | 0.0% |
| 2018 FY | 4.31 Million USD | 1504.83% |
| 2017 FY | 269 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 77.38 Million USD | -324.751% |
| Alkermes plc | 290.73 Million USD | -13.051% |
| Agenus Inc. | 350.24 Million USD | 6.16% |
| Aptorum Group Limited | 3.36 Million USD | -9674.931% |
| Ardelyx, Inc. | 55.98 Million USD | -487.103% |
| Dyadic International, Inc. | 136.92 Thousand USD | -239930.965% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -5925.151% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -140075.971% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -52740.903% |
| Novavax, Inc. | 280.63 Million USD | -17.117% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1239.223% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1440.819% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -72845.662% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -824.398% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -180.454% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -36177.263% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -429.476% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -2432.923% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1852.894% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -43.405% |
| Clearside Biomedical, Inc. | 43 Million USD | -664.336% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -363.075% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 87.748% |
| AlloVir, Inc. | 27.42 Million USD | -1098.265% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -185.377% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -153485.047% |
| Bicycle Therapeutics plc | 44.95 Million USD | -631.097% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -224.185% |
| ChromaDex Corporation | 3.27 Million USD | -9929.661% |
| Chimerix, Inc. | 2.14 Million USD | -15229.851% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1473.781% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -1095.823% |
| CRISPR Therapeutics AG | 238.63 Million USD | -37.732% |
| Precision BioSciences, Inc. | 31.26 Million USD | -951.145% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -217.447% |
| Fortress Biotech, Inc. | 88.59 Million USD | -270.995% |
| Fortress Biotech, Inc. | 88.59 Million USD | -270.995% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -4911.008% |
| ImmuCell Corporation | 11.96 Million USD | -2645.958% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -11344.011% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 38.28 Million USD | -758.443% |
| Innoviva, Inc. | 449.07 Million USD | 26.811% |
| IO Biotech, Inc. | 2.49 Million USD | -13078.508% |
| Jaguar Health, Inc. | 35.86 Million USD | -816.542% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -2175.492% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -5231.257% |
| ContextLogic Inc. | 6 Million USD | -5377.867% |
| MiMedx Group, Inc. | 48.09 Million USD | -583.324% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| NextCure, Inc. | 6.6 Million USD | -4876.109% |
| Onconetix, Inc. | 9.88 Million USD | -3224.697% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -103255.975% |
| Opthea Limited | 200.62 Million USD | -63.821% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -4192.216% |
| Vaxcyte, Inc. | 29.22 Million USD | -1024.665% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1277.986% |
| Precigen, Inc. | 7.09 Million USD | -4531.14% |
| Pharming Group N.V. | 171.54 Million USD | -91.595% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -136.404% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| PureTech Health plc | 25.51 Million USD | -1188.304% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -442.551% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -3236.094% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -762.566% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -19783.364% |
| Acelyrin, Inc. | 1.19 Million USD | -27426.968% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -113374.864% |
| Summit Therapeutics Inc. | 106.09 Million USD | -209.779% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -5194.33% |
| Senti Biosciences, Inc. | 37.66 Million USD | -772.596% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -4708.661% |
| Elevation Oncology, Inc. | 30.13 Million USD | -990.593% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -325317.822% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -381.712% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -15403.396% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -923.326% |
| Seer, Inc. | 28.25 Million USD | -1063.07% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -622.197% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -4579.271% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -409062.434% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -40557.0% |
| GT Biopharma, Inc. | 58 Thousand USD | -566575.862% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -56.405% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -215.479% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -9140.146% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -69094.105% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -19382.632% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -109197.206% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -144.359% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -33853.719% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -1186.085% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1212.483% |
| Aptose Biosciences Inc. | 1 Million USD | -32448.034% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -3796942.514% |
| Soligenix, Inc. | 3.49 Million USD | -9305.244% |
| Century Therapeutics, Inc. | 48.17 Million USD | -582.303% |
| Kura Oncology, Inc. | 17.2 Million USD | -1810.884% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -255.579% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -207920.253% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -15187.07% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -2252.025% |
| Autolus Therapeutics plc | 52.96 Million USD | -520.522% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -5909.728% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -685.489% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -43.255% |
| GRI Bio, Inc. | 14 Thousand USD | -2347557.143% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -2545.46% |
| IGM Biosciences, Inc. | 40.5 Million USD | -711.416% |
| INmune Bio, Inc. | 10.43 Million USD | -3049.104% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -82.974% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -5464.055% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -402289.814% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -39650.183% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -534.808% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -463.944% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -467.929% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 31.647% |
| Verastem, Inc. | 41.55 Million USD | -690.894% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -5986.519% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -2790.186% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -3249.353% |
| Histogen Inc. | 4.62 Million USD | -7011.034% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -9626.901% |
| Organovo Holdings, Inc. | 1.39 Million USD | -23477.618% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -614.478% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -6227.917% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1447.493% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1539347.307% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -288.556% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -157144.283% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -987.742% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -202387.725% |
| Apollomics, Inc. | 4.66 Million USD | -6951.534% |
| Amarin Corporation plc | 8.73 Million USD | -3661.84% |
| Mesoblast Limited | 118.92 Million USD | -176.374% |
| Turnstone Biologics Corp. | 3.21 Million USD | -10126.26% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -288.162% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -132965.587% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -236.73% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -73.036% |
| Better Therapeutics, Inc. | 14.88 Million USD | -2108.817% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -973.6% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -196.293% |
| NLS Pharmaceutics AG | 1.63 Million USD | -20017.693% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -5261.697% |
| Gritstone bio, Inc. | 104.77 Million USD | -213.693% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -11697.272% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -672443.483% |
| Avid Bioservices, Inc. | 207.83 Million USD | -58.142% |
| Insmed Incorporated | 1.2 Billion USD | 72.702% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -4797.512% |
| OmniAb, Inc. | 25.56 Million USD | -1185.834% |
| Alector, Inc. | 38.91 Million USD | -744.524% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -53.631% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -2069.309% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 31.303% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1580.585% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -420.322% |
| Immunic, Inc. | 1.33 Million USD | -24538.081% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -935.775% |
| Veracyte, Inc. | 12.63 Million USD | -2502.312% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 49.032% |
| FibroGen, Inc. | 170.45 Million USD | -92.82% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -3519.337% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -161084.046% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 94.33% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -888202.703% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -7657.187% |
| TG Therapeutics, Inc. | 110.79 Million USD | -196.649% |
| Galecto, Inc. | 249 Thousand USD | -131896.787% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -19628.211% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 80.413% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -4391.896% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -5989.902% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -11697.272% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1122.693% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -629.199% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -23062.227% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -626.572% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -661.361% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -581.482% |
| Vaxxinity, Inc. | 15.16 Million USD | -2066.878% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 61.274% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -31890.718% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -2900.201% |
| NexImmune, Inc. | 68.8 Thousand USD | -477558.446% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -2315469.959% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 87.84% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -83744.47% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -4659.224% |
| Ainos, Inc. | 5.96 Million USD | -5411.343% |
| Pluri Inc. | 29.61 Million USD | -1009.928% |
| Prothena Corporation plc | 11.83 Million USD | -2677.119% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1202.445% |
| Celularity Inc. | 65.41 Million USD | -402.426% |
| Rallybio Corporation | 392 Thousand USD | -83744.898% |
| Cue Biopharma, Inc. | 14.69 Million USD | -2136.625% |
| MeiraGTx Holdings plc | 89.26 Million USD | -268.202% |
| Omeros Corporation | 338.28 Million USD | 2.841% |
| Humacyte, Inc. | 58.1 Million USD | -465.642% |
| Immunocore Holdings plc | 84.03 Million USD | -291.127% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -17637.291% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -6639.225% |
| Blueprint Medicines Corporation | 774.12 Million USD | 57.543% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -6449.861% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -197.823% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -431.677% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -215.739% |
| Pulmatrix, Inc. | 8.75 Million USD | -3653.677% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -4651.655% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -2273.083% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -184.944% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -941.815% |
| Cytokinetics, Incorporated | 755.77 Million USD | 56.512% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -2355.708% |
| Nutriband Inc. | 241.28 Thousand USD | -136117.336% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -5911.926% |
| Vor Biopharma Inc. | 35.66 Million USD | -821.683% |
| Roivant Sciences Ltd. | 499.74 Million USD | 34.233% |
| Evogene Ltd. | 1.13 Million USD | -28781.547% |
| ProKidney Corp. | 4.41 Million USD | -7347.813% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -26708.483% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -595698.06% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 81.109% |
| CorMedix Inc. | 667.63 Thousand USD | -49129.516% |
| BioLineRx Ltd. | 11.59 Million USD | -2735.579% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -744.481% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -357.716% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1894.853% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -13309.732% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -48592.148% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -618.048% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -505549.231% |
| MediciNova, Inc. | 215.92 Thousand USD | -152115.111% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -13073.226% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -25963.815% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -76.353% |
| Biomea Fusion, Inc. | 10.29 Million USD | -3092.23% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 20.807% |
| Mereo BioPharma Group plc | 5.95 Million USD | -5422.043% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -9055.209% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -20002.263% |
| Absci Corporation | 15.95 Million USD | -1959.736% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -3487.731% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -2140.284% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1098.877% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -2581.286% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -2528.115% |
| Allakos Inc. | 41.46 Million USD | -692.649% |
| Imunon, Inc. | 1.62 Million USD | -20129.53% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -2937.353% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -217563.576% |
| BioAtla, Inc. | 2.46 Million USD | -13260.65% |
| NLS Pharmaceutics AG | 1.63 Million USD | -20017.693% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -290760.177% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -245.53% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -5826.289% |
| XOMA Corporation | 124.45 Million USD | -164.1% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1635.974% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -661.396% |
| aTyr Pharma, Inc. | 15.09 Million USD | -2077.357% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -2850.907% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1162.036% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1461.536% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -94075.358% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -100567.396% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -20042.61% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 78.078% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -200350.091% |
| UroGen Pharma Ltd. | 100.21 Million USD | -227.97% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -79.849% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -94798.106% |
| Orgenesis Inc. | 22.62 Million USD | -1352.951% |
| Entera Bio Ltd. | 390 Thousand USD | -84174.872% |
| GH Research PLC | 343 Thousand USD | -95722.741% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -107661.311% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -33679.239% |
| Xencor, Inc. | 83.43 Million USD | -293.931% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -190243.597% |
| Replimune Group, Inc. | 75.86 Million USD | -333.21% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -26747.33% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -3395.023% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -200350.091% |
| Portage Biotech Inc. | 47 Thousand USD | -699202.128% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -25963.815% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -13498.345% |
| OncoCyte Corporation | 2.86 Million USD | -11355.978% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -25197.718% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -218208.381% |
| Purple Biotech Ltd. | 351 Thousand USD | -93538.746% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -10304.305% |
| scPharmaceuticals Inc. | 40.26 Million USD | -716.191% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -542.025% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -231359.155% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -6183.158% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1129.232% |
| Curis, Inc. | 2.79 Million USD | -11663.493% |
| Daré Bioscience, Inc. | 5.31 Million USD | -6080.2% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -15284.032% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -58072.035% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1864.449% |
| BeiGene, Ltd. | 930.18 Million USD | 64.666% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -2014.666% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -273.729% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -28705.609% |
| Erasca, Inc. | 55.85 Million USD | -488.396% |
| bluebird bio, Inc. | 330.32 Million USD | 0.501% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 71.013% |
| DBV Technologies S.A. | 14.38 Million USD | -2185.46% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -13036.371% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 12.23 Million USD | -2587.424% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -6977.347% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 18.803% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -613.899% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -7031.091% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -12829.662% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1643.341% |
| MacroGenics, Inc. | 33.97 Million USD | -867.508% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -1470.79% |
| Prime Medicine, Inc. | 13.63 Million USD | -2310.856% |
| Aditxt, Inc. | 18.21 Million USD | -1704.107% |
| Adagene Inc. | 22.3 Million USD | -1373.411% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -2047.762% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 46.205% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1519.632% |
| SciSparc Ltd. | 76 Thousand USD | -432363.158% |
| Vericel Corporation | 88.14 Million USD | -272.885% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -300.737% |
| Generation Bio Co. | 97.89 Million USD | -235.743% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -99800.304% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1199.202% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -59.615% |
| Invivyd, Inc. | 2.16 Million USD | -15081.155% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -514.731% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -9327288.875% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -5829.497% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -521601.587% |
| 2seventy bio, Inc. | 256.67 Million USD | -28.051% |
| ADMA Biologics, Inc. | 141.41 Million USD | -132.412% |
| Clene Inc. | 32.16 Million USD | -921.958% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -5756.432% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -14873.667% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -548.626% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -68196.19% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -70.127% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -990.991% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1811.217% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -163.909% |
| Evaxion Biotech A/S | 10.86 Million USD | -2923.751% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -294.143% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -338.773% |
| Trevena, Inc. | 35.23 Million USD | -832.853% |
| Surrozen, Inc. | 3.37 Million USD | -9626.901% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -4959.606% |
| Cingulate Inc. | 3.13 Million USD | -10383.624% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -801539.024% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1117.755% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -65515.898% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -54406.136% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -474.551% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -70582.151% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -1062.535% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1525.56% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -21036.463% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -25985.079% |
| Statera Biopharma, Inc. | 16.26 Million USD | -1921.212% |
| ImmunityBio, Inc. | 883.67 Million USD | 62.806% |
| Korro Bio, Inc. | 33.2 Million USD | -889.767% |
| Kineta, Inc. | 1.31 Million USD | -24856.112% |
| BioVie Inc. | 6.11 Million USD | -5277.973% |
| Codexis, Inc. | 22.36 Million USD | -1369.648% |
| Celularity Inc. | 65.41 Million USD | -402.426% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -535.385% |
| Celcuity Inc. | 37.44 Million USD | -777.716% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -146432.323% |
| Cibus, Inc. | 24.62 Million USD | -1234.925% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -85715.144% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1590.265% |
| IN8bio, Inc. | 4.89 Million USD | -6617.188% |
| Kodiak Sciences Inc. | 181.63 Million USD | -80.955% |
| Annexon, Inc. | 31.35 Million USD | -948.228% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -338.019% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -13933.817% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -8321.009% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 77.388% |
| Eyenovia, Inc. | 16.1 Million USD | -1940.458% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -194.8% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -33267.716% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -2768.744% |
| Arcellx, Inc. | 97.62 Million USD | -236.668% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -15194.183% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1139.664% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -10495.487% |
| Moolec Science SA | 2.64 Million USD | -12324.805% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1053.761% |
| Geron Corporation | 85.89 Million USD | -282.626% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -5106.273% |
| Royalty Pharma plc | 6.13 Billion USD | 94.643% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -13583.264% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -285071.881% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -871.54% |
| Humacyte, Inc. | 58.1 Million USD | -465.642% |
| Structure Therapeutics Inc. | 5.45 Million USD | -5927.36% |
| 89bio, Inc. | 27.1 Million USD | -1112.454% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -2373.822% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -12947.717% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -24464.425% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -209.881% |
| Notable Labs, Ltd. | 2.04 Million USD | -15940.605% |
| Liquidia Corporation | 3.5 Million USD | -9282.586% |
| Mustang Bio, Inc. | 2.49 Million USD | -13057.406% |
| Immunovant, Inc. | 138 Thousand USD | -238068.116% |
| Quantum-Si incorporated | 15.3 Million USD | -2047.762% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -3668.742% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -82068.0% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -511.961% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -402289.814% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -2914.51% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -156046.877% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -161807.389% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1490.785% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -81456.328% |
| PepGen Inc. | 20.1 Million USD | -1534.859% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -57159.93% |
| United Therapeutics Corporation | 700 Million USD | 53.047% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -1151.369% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -7264.441% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -36996.163% |
| XOMA Corporation | 124.45 Million USD | -164.1% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -119853.285% |
| Bionomics Limited | 239.61 Million USD | -37.165% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -16058.907% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2375.685% |
| uniQure N.V. | 138.4 Million USD | -137.464% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -284.758% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -31748.062% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -33267.716% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -3519.337% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -18713.509% |
| Altimmune, Inc. | 671 Thousand USD | -48882.414% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 26.151% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2375.685% |
| Compugen Ltd. | 1.35 Million USD | -24228.053% |
| Peak Bio, Inc. | 10.72 Million USD | -2965.453% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -668.536% |
| Benitec Biopharma Inc. | 284 Thousand USD | -115629.577% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -288.708% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1549.877% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -2690.322% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -259.369% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1549.877% |
| Instil Bio, Inc. | 86.05 Million USD | -281.937% |
| argenx SE | 20 Million USD | -1543.36% |
| Immunome, Inc. | 1.65 Million USD | -19819.515% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -18865.493% |
| Verona Pharma plc | 51.32 Million USD | -540.324% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -3261.342% |
| Shattuck Labs, Inc. | 4.2 Million USD | -7721.799% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -90693.37% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -7761.086% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -56083.248% |
| Moolec Science SA | 2.64 Million USD | -12324.805% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -987.985% |
| AnaptysBio, Inc. | 17.81 Million USD | -1745.021% |
| Design Therapeutics, Inc. | 3.05 Million USD | -10676.131% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -125347.328% |
| NeurAxis, Inc. | 224.26 Thousand USD | -146458.459% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -2210.037% |
| Lumos Pharma, Inc. | 6.58 Million USD | -4891.222% |
| Achilles Therapeutics plc | 4.61 Million USD | -7021.82% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -3261.342% |
| 180 Life Sciences Corp. | 1.32 Million USD | -24798.092% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1824.295% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -21036.463% |
| Nutriband Inc. | 241.28 Thousand USD | -136117.336% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -3118.173% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -39690.799% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 12.054% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -991.97% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -8788.153% |
| Palisade Bio, Inc. | 369 Thousand USD | -88971.003% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -79098.072% |
| Beam Therapeutics Inc. | 173.17 Million USD | -89.794% |
| Neurogene Inc. | 16.25 Million USD | -1921.975% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -6.663% |
| AEON Biopharma, Inc. | 278 Thousand USD | -118127.338% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1051.578% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -98011.045% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -307383.324% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -333.25% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -437.863% |
| Athira Pharma, Inc. | 1.58 Million USD | -20636.404% |
| Vaccinex, Inc. | 247 Thousand USD | -132965.587% |
| HCW Biologics Inc. | 6.45 Million USD | -4994.286% |
| XOMA Corporation | 124.45 Million USD | -164.1% |
| Nektar Therapeutics | 230.4 Million USD | -42.652% |
| Arvinas, Inc. | 3.4 Million USD | -9566.824% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -20042.61% |
| Merus N.V. | 12.16 Million USD | -2602.45% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -155.919% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -2279.267% |
| Rezolute, Inc. | 2.22 Million USD | -14651.885% |
| Clene Inc. | 32.16 Million USD | -921.958% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -187655.708% |
| BeyondSpring Inc. | 3.99 Million USD | -8127.084% |
| Synlogic, Inc. | 17.27 Million USD | -1802.588% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -25182.462% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -938962.857% |
| Peak Bio, Inc. | 10.72 Million USD | -2965.453% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -532.999% |
| Krystal Biotech, Inc. | 8.09 Million USD | -3960.687% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -85.674% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -4557.39% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -240519.647% |
| MannKind Corporation | 382.37 Million USD | 14.045% |
| Ikena Oncology, Inc. | 10.73 Million USD | -2960.831% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -80259.902% |
| Gossamer Bio, Inc. | 212.46 Million USD | -54.695% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -188791.954% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -3487.731% |
| Mural Oncology plc | 15 Million USD | -2089.833% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -593.021% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -15543.598% |
| Champions Oncology, Inc. | 7.43 Million USD | -4323.58% |
| REGENXBIO Inc. | 89.29 Million USD | -268.095% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -38354.797% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -59336.293% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -5970.779% |
| Vaxart, Inc. | 26.51 Million USD | -1139.617% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1999.153% |
| Cellectis S.A. | 92.85 Million USD | -253.97% |
| Longeveron Inc. | 2.04 Million USD | -16003.479% |
| Repare Therapeutics Inc. | 3.41 Million USD | -9538.475% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 76.47% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -605.426% |
| Revolution Medicines, Inc. | 87.94 Million USD | -273.729% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -189883.815% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -8214.495% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -103582.019% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -187712.571% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 59.343% |
| Denali Therapeutics Inc. | 52.24 Million USD | -529.146% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -2181.579% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -23820.815% |
| Cingulate Inc. | 3.13 Million USD | -10383.624% |
| Passage Bio, Inc. | 26.29 Million USD | -1149.989% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -4831.313% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -80456.863% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -36664.206% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1498.521% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -25985.079% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -13309.048% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -10424.24% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -40426.757% |
| OmniAb, Inc. | 25.56 Million USD | -1185.834% |
| Anew Medical, Inc. | 1.6 Million USD | -20378.006% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1011.021% |
| Lipocine Inc. | 17.16 Thousand USD | -1914568.531% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -2724.128% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -849.151% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -5464.055% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -474.873% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -161807.389% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -6263.446% |
| Ocugen, Inc. | 6.94 Million USD | -4635.225% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2226.223% |
| Q32 Bio Inc. | 1.31 Million USD | -24837.178% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -48809.524% |
| Alumis Inc. Common Stock | 32.58 Million USD | -908.815% |
| Equillium, Inc. | 824 Thousand USD | -39787.379% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -3520.134% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -109163.778% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -115.807% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -542.716% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -42306.664% |
| Dominari Holdings Inc. | 3.02 Million USD | -10754.425% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -347748.91% |
| vTv Therapeutics Inc. | 529 Thousand USD | -62030.813% |
| Bio-Techne Corporation | 419.53 Million USD | 21.659% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -356.514% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -69.798% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1846.187% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1343.95% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -5325.421% |
| Nkarta, Inc. | 88.33 Million USD | -272.058% |
| BioCardia, Inc. | 1.31 Million USD | -24894.068% |
| Iterum Therapeutics plc | 19.5 Million USD | -1584.72% |